Showing 501-510 of 1517 results for "".
Advances in Cosmeceuticals and Makeup – State of the Art from the Innovators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advances-in-cosmeceuticals-and-makeup--state-of-the-art-from-the-innovators/21607/Experts from different arenas in cosmetic dermatology weigh in on current and future developments.New Products/New In My Practice: Devices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-devices-1/23438/Get More of the Patients You Want
https://practicaldermatology.com/topics/practice-management/get-more-of-the-patients-you-want/20520/How to use micro-targeted digital marketing to grow your practice.It's Us Versus It
https://practicaldermatology.com/topics/practice-management/its-us-versus-it/20618/Are we entering a dermatologist-free zone?Physician Spotlight: David A. Straker, DO
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-david-a-straker-do/20758/A specialist discusses the mind/skin connection and addresses the influence of prescription medications.Journal Club: Efficacy of Systemics After Discontinuation
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-efficacy-of-systemics-after-discontinuation/32829/Practical Dermatology chief medical editor Neal Bhatia, MD, FAAD, is joined by Naiem T. Issa, MD, PhD, to discuss an article Dr. Issa authored reviewing published literature on the efficacy of biologics as monotherapy for atopic dermatitis following discontinuation. Issa NT, Abdin R, et al.Leadership Pearls from a High-Performing Practice
https://practicaldermatology.com/topics/practice-management/leadership-pearls-from-a-high-performing-practice/23777/A successful practice shares tips for growth.How to Hire in a Challenging Market
https://practicaldermatology.com/topics/practice-management/how-to-hire-in-a-challenging-market/23728/Tips for finding and hiring qualified applicants.Treatment of Basal Cell Carcinomas in Elderly Patients
https://practicaldermatology.com/topics/general-topics/treatment-of-basal-cell-carcinomas-in-elderly-patients/21748/BCCs are increasingly prevalent in older patients. While surgery remains the gold standard of treatment, existing and emerging therapies may enhance outcomes.The Case for JAK Inhibitors to Treat AD
https://practicaldermatology.com/topics/atopic-dermatitis/case-jak-inhibitors-treat-ad/27109/E. James Song, MD, FAAD, Director of Clinical Research and Co-Chief Medical Officer for Frontier Dermatology, discusses his presentation “JAK Inhibitors in Atopic Dermatitis” from the 2024 American Academy of Dermatology (AAD) Innovation Academy.